Skip to content

Effect of Allopurinol Treatment on Insulin Resistance

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02008968
Enrollment
130
Registered
2013-12-11
Start date
2013-12-31
Completion date
2014-08-31
Last updated
2013-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperuricemia, Insulin Resistance, Prediabetes

Brief summary

Several studies showed that hyperuricemia is an independent risk factor for development of diabetes mellitus. However none of the previous studies have investigated the effect of lowering serum uric acid levels on insulin resistance of which is also named as prediabetes. With this background in mind, we aimed to test the effect of lowering serum uric acid level with allopurinol on insulin resistance.

Interventions

DRUGallopurinol 300 mg./day
OTHERNo intervention
DRUGNormouricemic

Sponsors

Istanbul Medeniyet University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Age ≥ 30 * Serum uric acid level ≥7mg/dL * Glomerular filtration rate ≥60 ml/min

Exclusion criteria

* presence of Diabetes Mellitus * history of gout * history of allopurinol use * body mass index ≥35 kg/m2 * proteinuria ≥ 1gr/ day * presence of autoimmune disease * rheumatology associated disease * presence of hypothyroidism or hyperthyroidism * presence of diseases which may cause chronic inflammation or microalbuminuria (e.g. malignancy, chronic liver disease, hypertension, chronic lung disease)

Design outcomes

Primary

MeasureTime frame
Change in insulin resistance (HOMA-IR)baseline and 3 months

Countries

Turkey (Türkiye)

Contacts

Primary ContactMehmet Kanbay, Associate Professor
drkanbay@yahoo.com+902165709294

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026